Vasileios C Kyttaris Selected Research

Cyclic AMP Response Element Modulator

11/2013	cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease.
12/2012	cAMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE).
2/2012	cAMP-responsive element modulator α (CREMα) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vasileios C Kyttaris Research Topics

Disease

49	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 09/2004
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2007
5	Rheumatoid Arthritis 01/2016 - 09/2005
5	Lupus Nephritis 01/2013 - 07/2008
4	Nephritis 01/2021 - 09/2009
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 11/2018
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 06/2021
2	Rheumatic Diseases (Rheumatism) 01/2022 - 06/2021
2	Arthritis (Polyarthritis) 12/2020 - 10/2012
2	Infections 01/2020 - 01/2012
2	Inflammation (Inflammations) 01/2016 - 06/2010
1	Encephalomyelitis (Myeloencephalitis) 01/2022
1	Cytopenia 12/2020
1	Serositis 12/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Bone Resorption 01/2017
1	Splenomegaly 10/2016
1	Lymphadenopathy 10/2016
1	Proteinuria 10/2016
1	Glomerulonephritis 10/2016
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2016
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2016
1	Autoimmune Lymphoproliferative Syndrome 11/2013
1	Orchitis 01/2012
1	Diarrhea 01/2012
1	Neutropenia 01/2012
1	Skin Ulcer 07/2011
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 07/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2007
1	Calciphylaxis 02/2007
1	Vasculitis (Vasculitides) 02/2007

Drug/Important Bio-Agent (IBA)

10	Interleukin-2 (IL2)IBA 01/2022 - 09/2004
7	AutoantibodiesIBA 01/2016 - 09/2005
6	Interleukin-17 (Interleukin 17)IBA 01/2022 - 12/2008
5	Interleukin-23 (Interleukin 23)IBA 12/2020 - 09/2009
5	CytokinesIBA 01/2018 - 09/2005
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2016 - 01/2012
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2013 - 07/2008
4	Transcription Factors (Transcription Factor)IBA 11/2013 - 02/2007
3	Immunoglobulin G (IgG)IBA 01/2022 - 04/2005
3	AntigensIBA 01/2022 - 09/2005
3	RNA Splicing FactorsIBA 11/2021 - 01/2020
3	Signaling Lymphocytic Activation Molecule FamilyIBA 01/2017 - 01/2016
3	Cyclic AMP Response Element ModulatorIBA 11/2013 - 02/2012
3	Syk KinaseIBA 01/2013 - 09/2007
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 04/2011
3	CalciumIBA 02/2007 - 09/2005
2	Rituximab (Mabthera)FDA Link 01/2022 - 06/2021
2	AntibodiesIBA 10/2016 - 01/2015
2	Complement System Proteins (Complement)IBA 01/2015 - 02/2011
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2011 - 09/2004
2	CalcineurinIBA 07/2011 - 02/2007
2	Protein Isoforms (Isoforms)IBA 04/2011 - 05/2010
2	Messenger RNA (mRNA)IBA 04/2011 - 11/2005
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2011 - 11/2005
1	VaccinesIBA 01/2022
1	Sirtuin 2IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Arginine (L-Arginine)FDA Link 11/2021
1	Estrogens (Estrogen)FDA Link 11/2021
1	Serine (L-Serine)FDA Link 11/2021
1	GlucocorticoidsIBA 06/2021
1	GlobulinsIBA 01/2021
1	NAD (NADH)IBA 01/2020
1	Sulfides (Thioethers)IBA 11/2019
1	GlutaminaseIBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Signaling Lymphocytic Activation Molecule Family Member 1IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 11/2018
1	Peptides (Polypeptides)IBA 01/2017
1	Cathepsin KIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Protein Tyrosine PhosphatasesIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	Biological ProductsIBA 09/2013
1	anti-dsDNA autoantibodyIBA 01/2013
1	IntegrinsIBA 10/2012
1	fostamatinibIBA 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	EnzymesIBA 01/2012
1	CreatinineIBA 01/2012
1	KinesinsIBA 01/2012
1	Antirheumatic Agents (DMARD)IBA 01/2012
1	tofacitinibIBA 01/2012
1	p38 Mitogen-Activated Protein KinasesIBA 01/2012
1	LipidsIBA 01/2012
1	Dipyridamole (Persantine)FDA LinkGeneric 07/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2011
1	Type II Tumor Necrosis Factor ReceptorsIBA 06/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010
1	Type I Tumor Necrosis Factor ReceptorsIBA 06/2010
1	AutoantigensIBA 01/2010
1	CD3 ComplexIBA 09/2008
1	CryoglobulinsIBA 07/2008
1	ezrinIBA 02/2007
1	radixinIBA 02/2007

Therapy/Procedure

3	Therapeutics 06/2021 - 09/2007
1	Intradermal Injections 06/2010